Analysis of the entire cohort of hematologic malignancies revealed 67 of 1348 cases (5.0%) harboring a rare germline ERBB2 coding variant, compared to 7 of 256 (2.7%) in the control cohort (Table S3). The gene discussed is ERBB2; the disease is hematologic disorder.